Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tetsuya Haruna is active.

Publication


Featured researches published by Tetsuya Haruna.


Circulation-arrhythmia and Electrophysiology | 2009

Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-induced Long QT Syndrome

Hideki Itoh; Tomoko Sakaguchi; Wei-Guang Ding; Eiichi Watanabe; Ichirou Watanabe; Yukiko Nishio; Takeru Makiyama; Seiko Ohno; Masaharu Akao; Yukei Higashi; Naoko Zenda; Tomonori Kubota; Chikara Mori; Katsunori Okajima; Tetsuya Haruna; Akashi Miyamoto; Mihoko Kawamura; Katsuya Ishida; Iori Nagaoka; Yuko Oka; Yuko Nakazawa; Takenori Yao; Hikari Jo; Yoshihisa Sugimoto; Takashi Ashihara; Hideki Hayashi; Makoto Ito; Keiji Imoto; Hiroshi Matsuura; Minoru Horie

Background—Drugs with IKr-blocking action cause secondary long-QT syndrome. Several cases have been associated with mutations of genes coding cardiac ion channels, but their frequency among patients affected by drug-induced long-QT syndrome (dLQTS) and the resultant molecular effects remain unknown. Methods and Results—Genetic testing was carried out for long-QT syndrome–related genes in 20 subjects with dLQTS and 176 subjects with congenital long-QT syndrome (cLQTS); electrophysiological characteristics of dLQTS-associated mutations were analyzed using a heterologous expression system with Chinese hamster ovary cells together with a computer simulation model. The positive mutation rate in dLQTS was similar to cLQTS (dLQTS versus cLQTS, 8 of 20 [40%] versus 91 of 176 [52%] subjects, P=0.32). The incidence of mutations was higher in patients with torsades de pointes induced by nonantiarrhythmic drugs than by antiarrhythmic drugs (antiarrhythmic versus others, 3 of 14 [21%] versus 5 of 6 [83%] subjects, P<0.05). When reconstituted in Chinese hamster ovary cells, KCNQ1 and KCNH2 mutant channels showed complex gating defects without dominant negative effects or a relatively mild decreased current density. Drug sensitivity for mutant channels was similar to that of the wild-type channel. With the Luo-Rudy simulation model of action potentials, action potential durations of most mutant channels were between those of wild-type and cLQTS. Conclusions—dLQTS had a similar positive mutation rate compared with cLQTS, whereas the functional changes of these mutations identified in dLQTS were mild. When IKr-blocking agents produce excessive QT prolongation (dLQTS), the underlying genetic background of the dLQTS subject should also be taken into consideration, as would be the case with cLQTS; dLQTS can be regarded as a latent form of long-QT syndrome.


European Heart Journal | 2015

Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial.

Atsushi Kobori; Satoshi Shizuta; Koichi Inoue; Kazuaki Kaitani; Takeshi Morimoto; Yuko Nakazawa; Tomoya Ozawa; Toshiya Kurotobi; Itsuro Morishima; Fumiharu Miura; Tetsuya Watanabe; Masaharu Masuda; Masaki Naito; Hajime Fujimoto; Taku Nishida; Yoshio Furukawa; Takeshi Shirayama; Mariko Tanaka; Katsunori Okajima; Takenori Yao; Yasuyuki Egami; Kazuhiro Satomi; Takashi Noda; Koji Miyamoto; Tetsuya Haruna; Tetsuma Kawaji; Takashi Yoshizawa; Toshiaki Toyota; Mitsuhiko Yahata; Kentaro Nakai

AIMS Most of recurrent atrial tachyarrhythmias after pulmonary vein isolation (PVI) for atrial fibrillation (AF) are due to reconnection of PVs. The aim of the present study was to evaluate whether elimination of adenosine triphosphate (ATP)-induced dormant PV conduction by additional energy applications during the first ablation procedure could reduce the incidence of recurrent atrial tachyarrhythmias. METHODS AND RESULTS We randomly assigned 2113 patients with paroxysmal, persistent, or long-lasting AF to either ATP-guided PVI (1112 patients) or conventional PVI (1001 patients). The primary endpoint was recurrent atrial tachyarrhythmias lasting for >30 s or those requiring repeat ablation, hospital admission, or usage of Vaughan Williams class I or III antiarrhythmic drugs at 1 year with the blanking period of 90 days post ablation. Among patients assigned to ATP-guided PVI, 0.4 mg/kg body weight of ATP provoked dormant PV conduction in 307 patients (27.6%). Additional radiofrequency energy applications successfully eliminated dormant conduction in 302 patients (98.4%). At 1 year, 68.7% of patients in the ATP-guided PVI group and 67.1% of patients in the conventional PVI group were free from the primary endpoint, with no significant difference (adjusted hazard ratio [HR] 0.89; 95% confidence interval [CI] 0.74-1.09; P = 0.25). The results were consistent across all the prespecified subgroups. Also, there was no significant difference in the 1-year event-free rates from repeat ablation for any atrial tachyarrhythmia between the groups (adjusted HR 0.83; 95% CI 0.65-1.08; P = 0.16). CONCLUSION In the catheter ablation for AF, we found no significant reduction in the 1-year incidence of recurrent atrial tachyarrhythmias by ATP-guided PVI compared with conventional PVI.


Circulation | 1998

Coordinate interaction between ATP-sensitive K+ channel and Na+, K+-ATPase modulates ischemic preconditioning

Tetsuya Haruna; Minoru Horie; Ichiro Kouchi; Ryuzo Nawada; Kunihiko Tsuchiya; Masaharu Akao; Hideo Otani; Tomoyuki Murakami; Shigetake Sasayama

BACKGROUND We reported that digoxin abolishes the infarct size (IS)-limiting effect of ischemic preconditioning (IPC). Because ATP-sensitive K+ (KATP) channels are involved in IPC, we studied whether Na+,K+-ATPase and KATP channels functionally interact, thereby modulating IPC. METHODS AND RESULTS Rabbits received 30 minutes of coronary artery occlusion followed by 3 hours of reperfusion. IPC was elicited by 5 minutes of occlusion followed by 10 minutes of reperfusion. The IS, expressed as a percentage of the area at risk, was 40.2+/-2.8% in control and 39.8+/-5.0% in digoxin pretreatment rabbits. Both IPC and pretreatment with cromakalim, a KATP channel opener, reduced IS to 11.8+/-1.8% and 13.4+/-2.6% (P<0. 05 versus control). Digoxin abolished the reduction in IS induced by IPC (33.5+/-3.3%), whereas it did not change that induced by cromakalim (18.8+/-3.0%). In patch-clamp experiments, digoxin was found to inhibit the opening of KATP channels in single ventricular myocytes in which ATP depletion had been induced by metabolic stress. In contrast, digoxin had little effect on the channel opening induced by cromakalim. Moreover, the inhibitory action of digoxin on channel activities was dependent on subsarcolemmal ATP concentration. CONCLUSIONS The IS-limiting effect of IPC is modulated by an interaction between KATP channels and Na+,K+-ATPase through subsarcolemmal ATP.


European Heart Journal | 2016

Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial

Kazuaki Kaitani; Koichi Inoue; Atsushi Kobori; Yuko Nakazawa; Tomoya Ozawa; Toshiya Kurotobi; Itsuro Morishima; Fumiharu Miura; Tetsuya Watanabe; Masaharu Masuda; Masaki Naito; Hajime Fujimoto; Taku Nishida; Yoshio Furukawa; Takeshi Shirayama; Mariko Tanaka; Katsunori Okajima; Takenori Yao; Yasuyuki Egami; Kazuhiro Satomi; Takashi Noda; Koji Miyamoto; Tetsuya Haruna; Tetsuma Kawaji; Takashi Yoshizawa; Toshiaki Toyota; Mitsuhiko Yahata; Kentaro Nakai; Hiroaki Sugiyama; Yukei Higashi

AIMS Substantial portion of early arrhythmia recurrence after catheter ablation for atrial fibrillation (AF) is considered to be due to irritability in left atrium (LA) from the ablation procedure. We sought to evaluate whether 90-day use of antiarrhythmic drug (AAD) following AF ablation could reduce the incidence of early arrhythmia recurrence and thereby promote reverse remodelling of LA, leading to improved long-term clinical outcomes. METHODS AND RESULTS A total of 2038 patients who had undergone radiofrequency catheter ablation for paroxysmal, persistent, or long-lasting AF were randomly assigned to either 90-day use of Vaughan Williams class I or III AAD (1016 patients) or control (1022 patients) group. The primary endpoint was recurrent atrial tachyarrhythmias lasting for >30 s or those requiring repeat ablation, hospital admission, or usage of class I or III AAD at 1 year, following the treatment period of 90 days post ablation. Patients assigned to AAD were associated with significantly higher event-free rate from recurrent atrial tachyarrhythmias when compared with the control group during the treatment period of 90 days [59.0 and 52.1%, respectively; adjusted hazard ratio (HR) 0.84; 95% confidence interval (CI) 0.73-0.96; P = 0.01]. However, there was no significant difference in the 1-year event-free rates from the primary endpoint between the groups (69.5 and 67.8%, respectively; adjusted HR 0.93; 95% CI 0.79-1.09; P = 0.38). CONCLUSION Short-term use of AAD for 90 days following AF ablation reduced the incidence of recurrent atrial tachyarrhythmias during the treatment period, but it did not lead to improved clinical outcomes at the later phase.


Circulation | 2005

Serial Changes of the Electrocardiogram During the Progression of Subarachnoidal Hemorrhage

Moriaki Inoko; Junji Nakashima; Tetsuya Haruna; Kimisato Nakano; Tetsuhiko Yanazume; Eisaku Nakane; Toru Kinugawa; Hisataka Ohwaki; Masatsune Ishikawa; Ryuji Nohara

A 69-year-old woman who had never evidenced heart disease was admitted to our hospital for the treatment of an aneurysm at the tip of the basilar artery. The aneurysm was treated by endovascular treatment using Guglielmi detachable coils. However, the aneurysm ruptured during the procedure, resulting in massive subarachnoid hemorrhage (SAH). The patient had convulsions and was orally intubated to control her respiration. Finally, the SAH was stopped by coil embolization. ECGs were serially recorded during the procedure (Figure). The tracing, which was normal before SAH, showed sinus tachycardia with frequent ventricular ectopics after 15 seconds, wide QRS …


Journal of Cardiovascular Pharmacology | 2003

Verapamil, a Ca2+ entry blocker, targets the pore-forming subunit of cardiac type KATP channel (Kir6.2).

Tomonori Ninomiya; Makoto Takano; Tetsuya Haruna; Yutaka Kono; Minoru Horie

This study investigated the mechanism by which verapamil, which blocks 10R1, l-type Ca2+ channel and the HERG channel, blocks ATP-sensitive K+ (KATP) channels. In whole cell patch experiments, verapamil reversibly inhibited cardiac type KATP (Kir6.2/SUR2A) channels previously activated by 100-&mgr;mol/L pinacidil. In inside-out patch experiments, verapamil inhibited the C-terminal truncated form of Kir6.2 (Kir6.2&Dgr;C36) in a concentration-dependent manner; half-maximal inhibition (IC50) was obtained at 11.5 ± 2.8 &mgr;mol/L when Kir6.2&Dgr;C36 was expressed without SUR2A. Verapamil also inhibited Kir6.2/SUR2A with a similar potency; IC50 was 8.9 ± 2.1 &mgr;mol/L for Kir6.2/SUR2A (not statistically different from the value for Kir6.2&Dgr;C36 alone). Thus, verapamil appeared to target the pore-forming subunit Kir6.2 rather than SUR2A, a member of ABC superfamily. Verapamil did not decrease the single-channel conductance, but increased the closed time of Kir6.2/SUR2A. The mutations of Kir6.2&Dgr;C36 (Kir6.2&Dgr;C36-R50G, -K185Q, -G334D), which have much lower ATP sensitivity, had no significant effect on verapamil block, suggesting that the site at which verapamil mediates KATP channel inhibition is not identical with that involved in ATP block.


PLOS ONE | 2016

Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan

Masayuki Shiba; Takao Kato; Moritoshi Funasako; Eisaku Nakane; Shoichi Miyamoto; Toshiaki Izumi; Tetsuya Haruna; Moriaki Inoko

Background Psoriasis vulgaris is a chronic inflammatory skin disease with an immune-genetic background. It has been reported as an independent risk factor for coronary heart disease (CHD) in the United States and Europe. The purpose of this study was to investigate the association between psoriasis and CHD in a hospital-based population in Japan. Methods For 113,065 in-hospital and clinic patients at our institution between January 1, 2011 and January 1, 2013, the diagnostic International Classification of Diseases (ICD)-10 codes for CHD, hypertension, dyslipidemia, diabetes, and psoriasis vulgaris were extracted using the medical accounting system and electronic medical record, and were analyzed. Results The prevalence of CHD (n = 5,167, 4.5%), hypertension (n = 16,476, 14.5%), dyslipidemia (n = 9,236, 8.1%), diabetes mellitus (n = 11,555, 10.2%), and psoriasis vulgaris (n = 1,197, 1.1%) were identified. The prevalence of CHD in patients with hypertension, dyslipidemia, diabetes, and psoriasis vulgaris were 21.3%, 22.2%, 21.1%, and 9.0%, respectively. In 1,197 psoriasis patients, those with CHD were older, more likely to be male, and had more number of the diseases surveyed by ICD-10 codes. Multivariate analysis showed that psoriasis vulgaris was an independent associated factor for CHD (adjusted odds ratio [OR]: 1.27; 95% confidence interval [CI]: 1.01–1.58; p = 0.0404) along with hypertension (adjusted OR: 7.78; 95% CI: 7.25–8.36; p < 0.0001), dyslipidemia (adjusted OR: 2.35; 95% CI: 2.19–2.52; p < 0.0001), and diabetes (adjusted OR: 2.86; 95% CI: 2.67–3.06; p < 0.0001). Conclusion Psoriasis vulgaris was independently associated with CHD in a hospital-based population in Japan.


American Journal of Cardiology | 2011

Effect on treadmill exercise capacity, myocardial ischemia, and left ventricular function as a result of repeated whole-body periodic acceleration with heparin pretreatment in patients with angina pectoris and mild left ventricular dysfunction.

Shoichi Miyamoto; Masatoshi Fujita; Moriaki Inoko; Muneo Oba; Ryohei Hosokawa; Tetsuya Haruna; Toshiaki Izumi; Yoshiaki Saji; Eisaku Nakane; Tomomi Abe; Koji Ueyama; Ryuji Nohara

Whole-body periodic acceleration (WBPA) has been developed as a passive exercise device capable of improving endothelial function by applying pulsatile shear stress to vascular endothelium. We hypothesized that treatment with WBPA improves exercise capacity, myocardial ischemia, and left ventricular (LV) function because of increased coronary and peripheral vasodilatory reserves in patients with angina. Twenty-six patients with angina who were not indicated for percutaneous coronary intervention and/or coronary artery bypass grafting were randomly assigned to remain sedentary (sedentary group) or undergo 20 sessions of WBPA with the motion platform for 4 weeks (WBPA group) in addition to conventional medical treatment. WBPA was applied at 2 to 3 Hz and approximately ±2.2 m/s² for 45 minutes. We repeated the symptom-limited treadmill exercise test and adenosine sestamibi myocardial scintigraphy. In the WBPA group, the exercise time until 0.1-mV ST-segment depression increased by 53% (p <0.01) and the double product at 0.1-mV ST-segment depression by 23% (p <0.001). Severity score of myocardial scintigraphy during adenosine infusion decreased from 20 ± 10 to 14 ± 8 (p <0.001) and severity score at rest also decreased from 13 ± 10 to 8 ± 10 (p <0.01). On scintigraphic images at rest, LV end-diastolic volume index decreased by 18% (p <0.01) with an augmentation of LV ejection fraction from 50 ± 16% to 55 ± 16% (p <0.01). In contrast, all studied parameters remained unchanged in the sedentary group. In conclusion, treatment with WBPA for patients with angina ameliorates exercise capacity, myocardial ischemia, and LV function.


Heart | 2017

Impact of the left ventricular mass index on the outcomes of severe aortic stenosis

Eri Minamino-Muta; Takao Kato; Takeshi Morimoto; Tomohiko Taniguchi; Moriaki Inoko; Tetsuya Haruna; Toshiaki Izumi; Shoichi Miyamoto; Eisaku Nakane; Kenichi Sasaki; Moritoshi Funasako; Koji Ueyama; Shinichi Shirai; Takeshi Kitai; Chisato Izumi; Kazuya Nagao; Tsukasa Inada; Eiji Tada; Akihiro Komasa; Katsuhisa Ishii; Naritatsu Saito; Ryuzo Sakata; Kenji Minatoya; Takeshi Kimura

Objective To elucidate the factors associated with high left ventricular mass index (LVMI) and to test the hypothesis that high LVMI is associated with worse outcome in severe aortic stenosis (AS). Methods We analysed 3282 patients with LVMI data in a retrospective multicentre registry enrolling consecutive patients with severe AS in Japan. The management strategy, conservative or initial aortic valve replacement (AVR), was decided by the attending physician. High LVMI was defined as LVMI >115 g/m2 for males and >95 g/m2 for females. We compared the risk between normal and high LVMI in the primary outcome measures compromising aortic valve-related death and heart failure hospitalisation. Results Age was mean 77 (SD 9.6) years and peak aortic jet velocity (Vmax) was 4.1 (0.9) m/s. The factors associated with high LVMI (n=2374) included female, body mass index ≥22, absence of dyslipidemia, left ventricular ejection fraction <50%, Vmax ≥4 m/s, regurgitant valvular disease, hypertension, anaemia and end-stage renal disease. In the conservative management cohort (normal LVMI: n=691, high LVMI: n=1480), the excess adjusted 5-year risk of high LVMI was significant (HR: 1.53, 95% CI 1.26 to 1.85, p<0.001). In the initial AVR cohort (normal LVMI: n=217, high LVMI: n=894), the risk did not differ significantly between the two groups (HR: 0.96, 95% CI 0.60 to 1.55, p=0.88). There was a significant interaction between the initial treatment strategy and the risk of high LVMI (p=0.016). Conclusions The deleterious impact of high LVMI on outcome was observed in patients managed conservatively, but not observed in patients managed with initial AVR. Trial registration number UMIN000012140; Post-results.


Cardiovascular Drugs and Therapy | 2001

Disopyramide and Its Metabolite Enhance Insulin Release from Clonal Pancreatic β-Cells by Blocking KATP Channels

Minoru Horie; Nobuhisa Mizuno; Keiko Tsuji; Tetsuya Haruna; Tomonori Ninomiya; Hitoshi Ishida; Yutaka Seino; Shigetake Sasayama

In an insulin-secreting pancreatic β-cell line (MIN6), insulin release was caused by disopyramide, an antiarrhythmic drug with Na-channel blocking action, and its main metabolite mono-isopropyl disopyramide (MIP). Insulin secretion, measured as immunoreactive insulin (IRI), was accelerated to 265.7% of the control by disopyramide and to 184.4% by MIP, with half-effective concentrations (EC50) of 30.9 ± 1.5 μM and 92.4 ± 2.2 μM. We tested the possibility that these drugs induce insulin release by inhibiting ATP-sensitive K+ (KATP) channels of MIN6 cells. In the cell-attached or ATP-free inside-out mode with patch membranes on MIN6 cells, K-selective channels were recorded with unitary conductance of 70.5 ± 3.5 pS (150 mM external K+ ions at room temperature). The channels were concluded to be MIN6-KATP channels because they were closed by extracellular high glucose (11.0 mM) or glibenclamide (200 nM) and were reversibly activated by diazoxide (50 μM). In the inside-out patch mode, they were inhibited by micromolar ATP. In both cell-attached and insideout mode, disopyramide and MIP inhibited single MIN6-KATP channels. In the inside-out mode, they produced a dose-dependent inhibition of channel activity: the half-blocking concentrations (IC50) were 4.8 ± 0.2 μM for disopyramide and 40.4 ± 3.1 μM for MIP. It was therefore concluded that both agents exert insulinotrphic effect through the inhibition of membrane KATP channels in MIN6 cells.

Collaboration


Dive into the Tetsuya Haruna's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Minoru Horie

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge